Status:
COMPLETED
Chlorhexidine Gluconate Bathing Education Video Among Hospitalized Patients
Lead Sponsor:
Duke University
Collaborating Sponsors:
Massachusetts General Hospital
Indiana University Health
Conditions:
Infections
Eligibility:
All Genders
Phase:
NA
Brief Summary
Chlorhexidine gluconate (CHG) bathing is an effective intervention to reduce hospitalized patient's risk of acquiring a central line-associated bloodstream infection (CLABSI). While daily CHG bathing ...
Detailed Description
For this study, approximately 16 inpatient units will be included; 8 will be randomized to the intervention (access to patient-facing CHG video) with the remaining units continuing with usual care (pr...
Eligibility Criteria
Inclusion
- Patients admitted to an intervention unit who require a CHG skin treatment
Exclusion
- CHG allergy
- Patients on comfort care
Key Trial Info
Start Date :
May 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06112626
Start Date
May 1 2024
End Date
September 30 2025
Last Update
October 15 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Hospital
Durham, North Carolina, United States, 27710
2
WakeMed Health and Hospitals
Raleigh, North Carolina, United States, 27610